Efficacy and safety of pre-emptive tapentadol on pain control in total knee arthroplasty: A randomized, double-blind, placebo-controlled trial

Table 3 Analgesic consumption in 24 hours in both the groups

Parameters (mean ± SD)		Placebo (n = 38)	Tapentadol (n = 37)	P value
Total analgesic consumption		4.00 ± 0.86	3.10 ± 0.86	< 0.005
Individual analgesic consumption in 24 hours (mg)	Paracetamol	2000 ± 305.00	1850 ± 309.00	0.004
	Diclofenac	125 ± 35.96	72.24 ± 41.78	0.008
	Tramadol	76.67 ± 54.83	40.38 ± 51.77	0.001